Ratchaphruek Hospital Public Company Limited (BK:RPH) — Market Cap & Net Worth
Market Cap & Net Worth: Ratchaphruek Hospital Public Company Limited (RPH)
Ratchaphruek Hospital Public Company Limited (BK:RPH) has a market capitalization of $83.49 Million (฿2.68 Billion) as of August 7, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #19868 globally and #304 in its home market, demonstrating a 1.41% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ratchaphruek Hospital Public Company Limited's stock price ฿5.05 by its total outstanding shares 530407000 (530.41 Million). See Ratchaphruek Hospital Public Company Lim capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Ratchaphruek Hospital Public Company Limited Market Cap History: 2017 to 2026
Ratchaphruek Hospital Public Company Limited's market capitalization history from 2017 to 2026. Data shows growth from $61.38 Million to $83.49 Million (1.95% CAGR).
Ratchaphruek Hospital Public Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ratchaphruek Hospital Public Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
Ratchaphruek Hospital Public Company Limited's market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.53x
Ratchaphruek Hospital Public Company Limited's market cap is 0.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $61.38 Million | $413.02 Million | $63.04 Million | 0.15x | 0.97x |
| 2018 | $63.85 Million | $532.89 Million | $48.43 Million | 0.12x | 1.32x |
| 2019 | $87.88 Million | $816.58 Million | $96.41 Million | 0.11x | 0.91x |
| 2020 | $75.89 Million | $799.33 Million | $93.84 Million | 0.09x | 0.81x |
| 2021 | $85.68 Million | $1.41 Billion | $402.99 Million | 0.06x | 0.21x |
| 2022 | $91.10 Million | $1.33 Billion | $286.47 Million | 0.07x | 0.32x |
| 2023 | $100.62 Million | $1.16 Billion | $184.45 Million | 0.09x | 0.55x |
| 2024 | $90.93 Million | $1.13 Billion | $172.53 Million | 0.08x | 0.53x |
Competitor Companies of RPH by Market Capitalization
Companies near Ratchaphruek Hospital Public Company Limited in the global market cap rankings as of August 7, 2026.
Key companies related to Ratchaphruek Hospital Public Company Limited by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #328 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #913 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #995 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1382 globally with a market cap of $18.46 Billion USD ( RM73.52 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #328 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $409.64 |
| #913 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €46.65 |
| #995 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1382 | IHH Healthcare Bhd | KLSE:5225 | $18.46 Billion | RM8.32 |
Ratchaphruek Hospital Public Company Limited Historical Marketcap From 2017 to 2026
Between 2017 and today, Ratchaphruek Hospital Public Company Limited's market cap moved from $61.38 Million to $ 83.49 Million, with a yearly change of 1.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ฿83.49 Million | +1.81% |
| 2025 | ฿82.00 Million | -9.82% |
| 2024 | ฿90.93 Million | -9.63% |
| 2023 | ฿100.62 Million | +10.44% |
| 2022 | ฿91.10 Million | +6.33% |
| 2021 | ฿85.68 Million | +12.90% |
| 2020 | ฿75.89 Million | -13.65% |
| 2019 | ฿87.88 Million | +37.65% |
| 2018 | ฿63.85 Million | +4.02% |
| 2017 | ฿61.38 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 6th, 2026 the market cap of Ratchaphruek Hospital Public Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $83.49 Million USD |
| MoneyControl | $83.49 Million USD |
| MarketWatch | $83.49 Million USD |
| marketcap.company | $83.49 Million USD |
| Reuters | $83.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ratchaphruek Hospital Public Company Limited
Ratchaphruek Hospital Public Company Limited engages in the hospital business under the Ratchaphruek Hospital name in Thailand. The company offers medical services in the field of internal medicine, such as diabetes and endocrine, dermatology, neurology, hematology, pulmonary, rheumatology, gastroenterology, nephrology, and cardiology; as well as operates stroke, breast, and hearing and balance m… Read more